Propofol Injection, Emulsion
Product Images NDC 0409-0010

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 0409-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propofol 01)

Chemical structure of propofol showing its molecular arrangement with a phenol ring and two isopropyl groups, representing the active ingredient in the PROPOFOL 10 mg/mL injection emulsion by Hospira, Inc.*

FDA Label Image

Graph (Propofol 02)

A line graph showing plasma propofol concentration (mcg/mL) over time (minutes) after end of infusion. It compares recovery profiles after 1 hour, 10 hour, and 10 day infusions, indicating how plasma levels decline and approach the awakening concentration threshold.*

FDA Label Image

Logo (Propofol 03)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for PROPOFOL Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Hospira, Inc. Includes warnings about benzyl alcohol content, microbial growth inhibition within 12 hours after opening, and uses aseptic technique. Lists ingredients per mL and storage instructions. The label also states the product is Rx only and provides distributor information.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Packaging label for PROPOFOL Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) distributed by Hospira, Inc. The label indicates the product contains benzyl alcohol and is for intravenous administration. It comes in a box of 5 x 20 mL vials for single patient use. The label includes warnings about microbial growth inhibition by benzyl alcohol and instructions to discard within 12 hours of opening, emphasizing strict aseptic technique.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label for PROPOFOL Injectable Emulsion USP 500 mg/50 mL (10 mg/mL) by Hospira, Inc. The label indicates it contains benzyl alcohol and is for intravenous administration. It instructs to shake well before using and notes single patient use only. The NDC is 0409-4699-53, with storage and dosage instructions partially visible.*

FDA Label Image

Principal Display Panel (50 mL Vial Tray)

Packaging label for PROPOFOL Injectable Emulsion, USP 500 mg/50 mL (10 mg/mL) injection, emulsion for intravenous administration. The box contains 20 x 50 mL vials. The label notes that it contains benzyl alcohol and is distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

PROPOFOL 10 mg/mL injectable emulsion for intravenous use in a 20 mL vial. The label indicates it contains 200 mg per 20 mL, with benzyl alcohol as a preservative. Instructions include shaking well before use, noting microbial inhibition up to 12 hours, and disposal recommendations. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (20 mL Vial Tray)

PROPOFOL Injectable Emulsion USP 200 mg/20 mL (10 mg/mL) injection for intravenous administration. The label indicates the product contains benzyl alcohol and is supplied in 25 x 20 mL vials. The manufacturer is Hospira, Inc. Storage instructions specify storing at 20° to 25°C, not freezing, and shaking well before use.*

FDA Label Image

Principal Display Panel (100 mL Vial)

Label for PROPOFOL Injectable Emulsion, USP 1,000 mg/100 mL (10 mg/mL) single-dose vial. The label includes a warning about benzyl alcohol inhibiting microbial growth and advises discarding within 12 hours of opening. It provides storage instructions, mentions the presence of benzyl alcohol and other ingredients, and shows the Hospira, Inc. logo and contact information.*

FDA Label Image

Principal Display Panel (100 mL Vial Carton)

Packaging label for PROPOFOL Injectable Emulsion, USP 1,000 mg/100 mL (10 mg/mL) by Hospira, Inc. The label specifies it contains benzyl alcohol for intravenous administration and comes in 10 x 100 mL single-dose vials. Storage and usage instructions, as well as safety warnings about benzyl alcohol's microbial inhibition properties, are included. The label also contains manufacturer information and a barcode.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

PROPOFOL 200 mg/20 mL (10 mg/mL) injectable emulsion label from Hospira, Inc. It is a single-dose vial for intravenous use containing propofol with benzyl alcohol as a preservative. The label includes dosage and storage instructions, ingredient details, and a barcode.*

FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Packaging label for PROPOFOL Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Hospira, Inc. The label indicates 25 single-dose 20 mL vials per package, containing benzyl alcohol as a preservative. It is marked for prescription use only and includes storage and handling instructions.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label of PROPOFOL Injectable Emulsion, USP 500 mg/50 mL (10 mg/mL) single-dose vial by Hospira, Inc. The label highlights it contains benzyl alcohol for intravenous administration and instructs to shake well before use. Additional storage and usage instructions are visible along with the NDC 0409-0501-97.*

FDA Label Image

Principal Display Panel (50 mL Vial Tray)

PROPOFOL Injectable Emulsion USP 500 mg/50 mL (10 mg/mL) intravenous injection emulsion carton label. Contains benzyl alcohol preservative. Pack includes 20 single-dose vials of 50 mL each. Labeler is Hospira, Inc. Includes handling warnings about microbial growth inhibition and storage instructions. Features SmartDose branding.*

FDA Label Image

Principal Display Panel (100 mL Vial Label)

The label for PROPOFOL Injectable Emulsion USP 1,000 mg/100 mL (10 mg/mL), a single-dose vial for intravenous administration. It highlights benzyl alcohol content for microbial inhibition with a usage warning to discard within 12 hours after opening. The label notes the requirement to shake well before use and includes storage instructions, manufacturer Hospira, Inc., and NDC 0409-0010-97.*

FDA Label Image

Principal Display Panel (100 mL Vial Tray)

Packaging label for PROPOFOL Injectable Emulsion, USP 1,000 mg/100 mL (10 mg/mL), a single-dose vial injection emulsion for intravenous use. Contains benzyl alcohol, indicated for intravenous administration. The label includes storage instructions, ingredient listing, and the labeler Hospira, Inc. The carton design features blue and white colors with warnings about benzyl alcohol and aseptic technique.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.